Results 81 to 90 of about 48,475 (244)

Safe tolerance rate of disodium pamidronate infusion in children [PDF]

, 2014
Preetika Pai, Kate Armon
openalex   +1 more source

Acute pseudogout after pamidronate infusion.

, 2008
International audienceA 72-year-old man, treated with a 60-mg intravenous infusion of pamidronate for shoulder hand syndrome, developed after few hours an acute pseudogout arthritis of his right knee.
Griffond, Vincent, Tisserand, Guillaume, Saccomani, Clarisse, Wendling, Daniel, Toussirot, Eric   +4 more
core   +1 more source

Uses and Effectiveness of Pamidronate Disodium for Treatment of Dogs and Cats with Hypercalcemia [PDF]

, 2005
Roger A. Hostutler, Dennis J. Chew, Jordan Q. Jaeger, Susan M. Klein, Deborah J. Henderson, Stephen P. DiBartola   +5 more
openalex   +1 more source

Effect of pamidronate and calcium on implant osseointegration in ovariectomized rats

Journal of Craniomaxillofacial Research, 2016
Introduction: Supplementation with minerals like calcium has been shown to be effective in preventing bone loss and increasing bone density. Thus, it can be assumed that if calcium supplementation is paired with bisphosphonates, greater benefit can be ...
Mehrnoush Momeni, Mahboube Hasheminasab, Moosa Mahmoodi, Mohammad Bayat   +3 more
doaj  

Pharmacokinetics of Pamidronate in Patients With Bone Metastases

, 2017
Background: Pamidronate is a secondgeneration bisphosphonate used in the treatment of tumor-induced hypercalcemia and in the management of bone metastases from breast cancer, myeloma, or prostate cancer.
Flesch, G., Burckhardt, P., Hauffe, S., Hess, U., Ford, J. M., Leyvraz, S., Bauer, J.   +6 more
core  

FRI0383 PAMIDRONATE IN CHRONIC NON-BACTERIAL OSTEOMYELITIS: A RANDOMIZED, PLACEBO-CONTROLLED PILOT TRIAL [PDF]

, 2019
Caroline Marie Andreasen, Anne Grethe Jurik, Bent Deleuran, Troels Bille Folkmar, Hans Christian Horn, Troels Herlin, Ellen‐Margrethe Hauge   +6 more
openalex   +1 more source

Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment

Clinics
OBJECTIVES: The present study was designed to evaluate the bone phenotypes and mechanisms involved in bone disorders associated with hepatic osteodystrophy. Hepatocellular disease was induced by carbon tetrachloride (CCl4).
Adriano L. Spirlandeli, Ingrid Dick-de-Paula, Ariane Zamarioli, Vanda Jorgetti, Leandra N.Z. Ramalho, Marcello H. Nogueira-Barbosa, Jose B. Volpon, Alceu A. Jordão, Fernando Q. Cunha, Sandra Y. Fukada, Francisco J.A. de Paula   +10 more
doaj   +1 more source

Successful treatment of calciphylaxis with pamidronate

, 2015
Calciphylaxis is a complication of chronic kidney disease characterized by necrotic lesion in the skin. Histological examination reveals microcalcification of medium-sized blood vessels.
Hooman, N., Naghshi-Zadiyan, R., Mehrazma, M., Jahangiri, F.   +3 more
core  

Influence of zoledronic acid and pamidronate on tooth eruption in children with osteogenesis imperfecta

Introduction: Osteogenesis imperfecta (OI) is a congenital disease comprising a heterogeneous group of inherited connective tissue disorders. The main treatment in children is bisphosphonate therapy.
Nova García, Manuel Joaquín De, Del Río Cantero, Natalia, Sagastizábal Cardelús, Belén, Mourelle Martínez, Rosa   +3 more
core   +1 more source

Metabolic effects of pamidronate in patients with metastatic bone disease [PDF]

, 1996
J. Vinholes, C‐Y. Guo, OP Purohit, Richard Eastell, RE Coleman   +4 more
openalex   +1 more source